Dr. Reddy’s Sees Profit Drop As Pricing Pressure Hits Generics Industry
This article was originally published in The Pink Sheet Daily
Executive Summary
Revenues rose 25 percent, however, driven by North American markets.
You may also be interested in...
Amgen And India’s Jubilant In Drug Discovery Partnership
Collaboration continues trend of Indian CROs involved early in the discovery process.
Ranbaxy: Rivals Meddling With Daiichi Sankyo Deal; Congress Enters Fray
CEO Singh goes on TV to say global pharma industry trying to scuttle his deal.
India Patent Disputes Heat Up For Big Pharma
Patient advocacy groups organize to appose applications they say impede access.